Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome

Objectives: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instill...

Full description

Bibliographic Details
Main Authors: R. Waked, J. Choucair, N. Chehata, E. Haddad, G. Saliba
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405579420300073
_version_ 1828473022617485312
author R. Waked
J. Choucair
N. Chehata
E. Haddad
G. Saliba
author_facet R. Waked
J. Choucair
N. Chehata
E. Haddad
G. Saliba
author_sort R. Waked
collection DOAJ
description Objectives: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instillation for bladder tumor encountered at our institution for the past 5 years. Methods: Medical records of a tertiary teaching hospital, located in Beirut, Lebanon, were retrospectively analyzed from June 2014 to June 2019 searching for severe related complications of BCG. A comprehensive review of articles on this subject was conducted. Results: The incidence of severe systemic adverse events related to BCG instillation was 1.5% (5 out of 332 patients). A total of five patients were found to have a severe BCG related complication, with fever, chills, and irritative urinary signs being the most frequent symptoms. All patients received antituberculosis therapy (Isoniazid, Rifampin and Ethambutol). Two were put on add-on corticosteroids. Three patients had a computed tomography scan image in favor of an infection. Two patients had a favorable outcome, three patients died. Conclusion: BCG severe adverse events were mostly seen in patients with a traumatic instillation. Treatment used at our institution was similar to most cases reported in the literature. A standardized diagnostic and treatment approach should be implemented to help physicians tackle these life-threatening complications.
first_indexed 2024-12-11T05:38:14Z
format Article
id doaj.art-92737d143b1c4a3d8b0067747de20005
institution Directory Open Access Journal
issn 2405-5794
language English
last_indexed 2024-12-11T05:38:14Z
publishDate 2020-05-01
publisher Elsevier
record_format Article
series Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
spelling doaj.art-92737d143b1c4a3d8b0067747de200052022-12-22T01:19:13ZengElsevierJournal of Clinical Tuberculosis and Other Mycobacterial Diseases2405-57942020-05-0119Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcomeR. Waked0J. Choucair1N. Chehata2E. Haddad3G. Saliba4Department of Infectious Diseases, Faculty of Medicine, Saint Joseph University, Damascus street, PO BOX 11-5076, Riad El Solh, Beirut 1107 2180, Lebanon; Corresponding author.Coordinator of the Infectious Diseases department, Saint Joseph University, Beirut, LebanonDepartment of Infectious Diseases, Faculty of Medicine, Saint Joseph University, Damascus street, PO BOX 11-5076, Riad El Solh, Beirut 1107 2180, LebanonDepartment of Infectious Diseases, Faculty of Medicine, Saint Joseph University, Damascus street, PO BOX 11-5076, Riad El Solh, Beirut 1107 2180, LebanonDepartment of Infectious Diseases, Faculty of Medicine, Saint Joseph University, Damascus street, PO BOX 11-5076, Riad El Solh, Beirut 1107 2180, LebanonObjectives: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instillation for bladder tumor encountered at our institution for the past 5 years. Methods: Medical records of a tertiary teaching hospital, located in Beirut, Lebanon, were retrospectively analyzed from June 2014 to June 2019 searching for severe related complications of BCG. A comprehensive review of articles on this subject was conducted. Results: The incidence of severe systemic adverse events related to BCG instillation was 1.5% (5 out of 332 patients). A total of five patients were found to have a severe BCG related complication, with fever, chills, and irritative urinary signs being the most frequent symptoms. All patients received antituberculosis therapy (Isoniazid, Rifampin and Ethambutol). Two were put on add-on corticosteroids. Three patients had a computed tomography scan image in favor of an infection. Two patients had a favorable outcome, three patients died. Conclusion: BCG severe adverse events were mostly seen in patients with a traumatic instillation. Treatment used at our institution was similar to most cases reported in the literature. A standardized diagnostic and treatment approach should be implemented to help physicians tackle these life-threatening complications.http://www.sciencedirect.com/science/article/pii/S2405579420300073Mycobacterial infectionIntravesical Bacillus Calmette-GuérinBacillus Calmette-GuerinUrothelial bladder cancerSevere complicationTreatment protocol
spellingShingle R. Waked
J. Choucair
N. Chehata
E. Haddad
G. Saliba
Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Mycobacterial infection
Intravesical Bacillus Calmette-Guérin
Bacillus Calmette-Guerin
Urothelial bladder cancer
Severe complication
Treatment protocol
title Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
title_full Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
title_fullStr Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
title_full_unstemmed Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
title_short Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
title_sort intravesical bacillus calmette guerin bcg treatment s severe complications a single institution review of incidence presentation and treatment outcome
topic Mycobacterial infection
Intravesical Bacillus Calmette-Guérin
Bacillus Calmette-Guerin
Urothelial bladder cancer
Severe complication
Treatment protocol
url http://www.sciencedirect.com/science/article/pii/S2405579420300073
work_keys_str_mv AT rwaked intravesicalbacilluscalmetteguerinbcgtreatmentsseverecomplicationsasingleinstitutionreviewofincidencepresentationandtreatmentoutcome
AT jchoucair intravesicalbacilluscalmetteguerinbcgtreatmentsseverecomplicationsasingleinstitutionreviewofincidencepresentationandtreatmentoutcome
AT nchehata intravesicalbacilluscalmetteguerinbcgtreatmentsseverecomplicationsasingleinstitutionreviewofincidencepresentationandtreatmentoutcome
AT ehaddad intravesicalbacilluscalmetteguerinbcgtreatmentsseverecomplicationsasingleinstitutionreviewofincidencepresentationandtreatmentoutcome
AT gsaliba intravesicalbacilluscalmetteguerinbcgtreatmentsseverecomplicationsasingleinstitutionreviewofincidencepresentationandtreatmentoutcome